Prelude Therapeutics Statistics
NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.83+0.02 (+0.52%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Prelude Therapeutics by the numbers
Prelude Therapeutics has a market capitalization of $305.6 million based on 65.08M shares outstanding. With trailing EPS of $-0.73, Prelude Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.1% below its 50-day average and 1.9% below its 200-day average.
Average daily trading volume is 477.81K shares, or about $1.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PRLD valuation vs. peer median
| Metric | PRLD | Peer median | Difference |
|---|---|---|---|
| Market cap | $305.65M | $288.90M | +6% |
| Avg. volume | 477.81K | 1.37M | -65% |
Peer median across 8 companies: INDP, BNTC, ABEO, BIOA, LRMR, CATX, FULC, CYPH.
Valuation
- Market cap
- $305.65M
- EPS (TTM)
- $-0.73
- Shares outstanding
- 65.08M
Price and trading
- Previous close
- 3.81
- Open
- 3.75
- Day range
- 3.69 – 3.93
- 52-week range
- 1.15 – 6.83
- 52-week change
- +165.97%
- Beta
- —
- Volume
- 454.55K
- Average volume
- 477.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 305.65M
- Forward Pe
- -6.96
- Eps
- -0.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.83
- Week52 Low
- 1.15
- Avg Volume
- 477.81K
- Shares Outstanding
- 65.08M
- Ma50
- 4.98
- Ma200
- 3.90
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -43.92%
- Pct From52w Low
- 233.04%